Proprotein convertase subtilisin/kexin type 6 activates the extracellular signal‑regulated kinase 1/2 and Wnt family member 3A pathways and promotes in vitro proliferation, migration and invasion of breast cancer MDA‑MB‑231 cells

Wang,Ping; Wang,Feifei; Wang,Lin; Pan,Jihong

doi:10.3892/ol.2018.8654

July-2018 Volume 16 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2018 Volume 16 Issue 1

Full Size Image

Article Open Access

Proprotein convertase subtilisin/kexin type 6 activates the extracellular signal‑regulated kinase 1/2 and Wnt family member 3A pathways and promotes in vitro proliferation, migration and invasion of breast cancer MDA‑MB‑231 cells

Authors:
- Ping Wang
- Feifei Wang
- Lin Wang
- Jihong Pan
View Affiliations / Copyright

Affiliations: Anesthesia Department, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250000, P.R. China

Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 145-150
|
Published online on: May 7, 2018

https://doi.org/10.3892/ol.2018.8654
Expand metrics +

Abstract

Breast cancer progression results from the acquisition of genetic and epigenetic alterations that promote tumor cell proliferation and survival. Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a proteinase that regulates the proteolytic activity of various precursor proteins as well as protein maturation. PCSK6 also influences cancer cell proliferation, invasion and migration. Therefore, to investigate the effects of PCSK6 in breast cancer, human breast cancer MDA‑MB‑231 cells were treated with recombinant human PCSK6 in vitro. Treatment with recombinant PCSK6 significantly increased the proliferation, invasion and migration abilities of MDA‑MB‑231 cells. In addition, PCSK6 treatment reduced cell cycle arrest and prevented apoptosis of MDA‑MB‑231 cells. This provides further support for the hypothesis that PCSK6 serves a role in promoting tumor cell proliferation. PCSK6 treatment also increased the expression of phosphorylated extracellular signal‑regulated kinase 1/2 and Wnt family member 3A, suggesting that these pathways are activated by PCSK6. The results of the present study suggested that PCSK6 may promote the proliferation of breast cancer MDA‑MB‑231 cells by disturbing cell cycle arrest via the mitogen‑activated protein kinase pathway. Therefore, PCSK6 may be a potential therapeutic target for breast cancer.

View Figures

View References

1	La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P and Levi F: Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol. 21:1323–1360. 2010. View Article : Google Scholar : PubMed/NCBI
2	Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K and Sarkar S: Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res. 34:1071–1077. 2014.PubMed/NCBI
3	Seidah NG and Chrétien M: Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:45–62. 1999. View Article : Google Scholar : PubMed/NCBI
4	Nagahama M, Taniguchi T, Hashimoto E, Imamaki A, Mori K, Tsuji A and Matsuda Y: Biosynthetic processing and quaternary interactions of proprotein convertase SPC4 (PACE4). FEBS Lett. 434:155–159. 1998. View Article : Google Scholar : PubMed/NCBI
5	Mains RE, Berard CA, Denault JB, Zhou A, Johnson RC and Leduc R: PACE4: A subtilisin-like endoprotease with unique properties. Biochem J. 321:587–593. 1997. View Article : Google Scholar : PubMed/NCBI
6	Couture F, D'Anjou F, Desjardins R, Boudreau F and Day R: Role of proprotein convertases in prostate cancer progression. Neoplasia. 14:1032–1042. 2012. View Article : Google Scholar : PubMed/NCBI
7	Longuespée R, Couture F, Levesque C, Kwiatkowska A, Desjardins R, Gagnon S, Vergara D, Maffia M, Fournier I, Salzet M and Day R: Implications of proprotein convertases in ovarian cancer cell proliferation and tumor progression: Insights for PACE4 as a therapeutic target. Transl Oncol. S1936–S5233. 2014.
8	Bassi DE, Zhang J, Cenna J, Litwin S, Cukierman E and Klein-Szanto AJ: Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. Neoplasia. 12:516–526. 2010. View Article : Google Scholar : PubMed/NCBI
9	Lapierre M, Siegfried G, Scamuffa N, Bontemps Y, Calvo F, Seidah NG and Khatib AM: Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: Role of tissue inhibitors of metalloproteinase-1. Cancer Res. 67:9030–9034. 2007. View Article : Google Scholar : PubMed/NCBI
10	Wang F, Wang L, Jiang H, Chang X and Pan J: Inhibition of PCSK6 may play a protective role in the development of rheumatoid arthritis. J Rheumatol. 42:161–169. 2015. View Article : Google Scholar : PubMed/NCBI
11	Sansone P and Bromberg J: Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
12	Akiyama T and Kawasaki Y: Wnt signalling and the actin cytoskeleton. Oncogene. 25:7538–7544. 2006. View Article : Google Scholar : PubMed/NCBI
13	Larue L and Delmas V: The WNT/Beta-catenin pathway in melanoma. Front Biosci. 11:733–742. 2006. View Article : Google Scholar : PubMed/NCBI
14	Lai SL, Chien AJ and Moon RT: Wnt/Fz signaling and the cytoskeleton: Potential roles in tumorigenesis. Cell Res. 19:532–545. 2009. View Article : Google Scholar : PubMed/NCBI
15	Teo JL and Kahn M: The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Adv Drug Deliv Rev. 62:1149–1155. 2010. View Article : Google Scholar : PubMed/NCBI
16	Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
17	Bontemps Y, Scamuffa N, Calvo F and Khatib AM: Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases. Med Res Rev. 27:631–648. 2007. View Article : Google Scholar : PubMed/NCBI
18	Basak A: Inhibitors of proprotein convertases. J Mol Med. 83:844–855. 2005. View Article : Google Scholar : PubMed/NCBI
19	Wang F, Wang L and Pan J: PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells. Mol Med Rep. 11:698–704. 2015. View Article : Google Scholar : PubMed/NCBI
20	Fu J, Bassi DE, Zhang J, Li T, Cai KQ, Testa CL, Nicolas E and Klein-Szanto AJ: Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. Neoplasia. 15:169–179. 2013. View Article : Google Scholar : PubMed/NCBI
21	Li M, Lewis B, Capuco AV, Laucirica R and Furth PA: WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis. Oncogene. 19:1010–1019. 2000. View Article : Google Scholar : PubMed/NCBI